Table 5. Occurrence of adverse effects during the experimental period in different groups.
| Adverse effect | % of subjects | ||
|---|---|---|---|
| GC (n=15) | GAtb (n=15) | GProb (n=15) | |
| Headache | 0 | 60% | 0 |
| Stomachache | 0 | 7% | 0 |
| Nausea or Vomiting | 0 | 27% | 0 |
| Metallic taste in the mouth | 0 | 33% | 0 |
| Diarrhea or abdominal pain | 0 | 27% | 0 |
| Sleepiness | 0 | 20% | 0 |
| Itchy skin | 0 | 0% | 0 |
| Skin wounds | 0 | 0% | 0 |